Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Incidence of diabetes mellitus and obesity and the overlap of comorbidities in HIV+ hispanics initiating antiretroviral therapy

  • Angelina Gomes
  • , Emily V. Reyes
  • , L. Sergio Garduno
  • , Rita Rojas
  • , Geraldine Mir Mesejo
  • , Eliza Del Rosario
  • , Lina Jose
  • , Carmen Javier
  • , Catherine Vaughan
  • , Yeycy Donastorg
  • , Scott Hammer
  • , Karen Brudney
  • , Barbara S. Taylor

Producción científica: Article › revisión exhaustiva

Resumen

Background Cardiovascular disease (CVD) is a leading health threat for HIV+ patients on antiretroviral therapy (ART); cardiometabolic comorbidities are key predictors of risk. Data are limited on incidence of metabolic comorbidities in HIV+ individuals initiating ART in low and middle income countries (LMICs), particularly for Hispanics. We examined incidence of diabetes and obesity in a prospective cohort of those initiating ART in the Dominican Republic. Methods Participants 18 years, initiating ART <90 days prior to study enrollment, were examined for incidence of impaired fasting glucose (IFG), diabetes mellitus (DM), overweight, and obesity. Fasting plasma glucose (FPG) 100-125mg/dl defined IFG; FPG 126 mg/dl, diagnosis per medical record, or use of hypoglycemic medication defined DM. Overweight and obesity were BMI 25-30 and 30kg/m2 , respectively. Dyslipidemia was total cholesterol 40mg/dl or use of lipid-lowering medication. Framingham risk equation was used to determine ten-year CVD risk at the end of observation. Results Of 153 initiating ART, 8 (6%) had DM and 23 (16%) had IFG at baseline, 6 developed DM (28/1000 person-years follow up [PYFU]) and 46 developed IFG (329/1000 PYFU). At baseline, 24 (18%) were obese and 36 (27%) were overweight, 15 became obese (69/1000 YFU) and 22 became overweight (163/1000 PYFU). Median observation periods for the diabetes and obesity analyses were 23.5 months and 24.3 months, respectively. Increased CVD risk (10% 10-year Framingham risk score) was present for 13% of the cohort; 79% of the cohort had 1 cardiometabolic comorbidity, 48% had 2, and 13% had all three. Conclusions In this Hispanic cohort in an LMIC, incidences of IFG/DM and overweight/obesity were similar to or higher than that found in high income countries, and cardiometabolic disorders affected three-quarters of those initiating ART. Care models incorporating cardiovascular risk reduction into HIV treatment programs are needed to prevent CVD-associated mortality in this vulnerable population.

Idioma originalEnglish (US)
Número de artículoe0160797
PublicaciónPloS one
Volumen11
N.º8
DOI
EstadoPublished - ago 2016

ASJC Scopus subject areas

  • General

Huella

Profundice en los temas de investigación de 'Incidence of diabetes mellitus and obesity and the overlap of comorbidities in HIV+ hispanics initiating antiretroviral therapy'. En conjunto forman una huella única.

Citar esto